Northland-Bio 诺思兰德
21 significant filings since 1 Jun 2026: 17 on share issue, 1 on guarantee or financial assistance and 2 on issue review inquiry, and 1 other kind. The latest, on 14 Sep 2026: 关于披露2026年度向特定对象发行股票募集说明书（草案）（修订稿）的提示性公告. On 26 Aug 2026 the company said it expects net profit for the period ending 30 Sep 2026 to change by an amount it did not state from the same period a year earlier.
自 1 Jun 2026 起有 21 份重大公告：share issue 17 份、guarantee or financial assistance 1 份、issue review inquiry 2 份，另有 1 类。最新一份（14 Sep 2026）：关于披露2026年度向特定对象发行股票募集说明书（草案）（修订稿）的提示性公告。26 Aug 2026 公司预告截至 30 Sep 2026 的净利润较上年同期变动幅度未披露。
Price History 价格走势
250 trading days 个交易日 · High 最高 ¥34.89 · Low 最低 ¥14.26| FY2026 | FY2027 | |
|---|---|---|
| Now 当前 | 1 broker | 1 broker |
| 7 days ago | 1 broker | 1 broker |
| 30 days ago | 1 broker | 1 broker |
| 60 days ago | 1 broker | 1 broker |
| 90 days ago | 1 broker | 1 broker |
Consensus is the median of each broker's latest forecast from the 120 days before each date. With fewer than 3 brokers, the broker count is shown. 一致预期为各券商在该日期前 120 天内最新预测的中位数；不足 3 家时显示券商数。
| FY2026 | FY2027 | |
|---|---|---|
| Last 30 days | ▲ 0 ▼ 0 = 1 | ▲ 0 ▼ 0 = 1 |
| Last 90 days | ▲ 0 ▼ 0 = 1 | ▲ 0 ▼ 0 = 1 |
Each broker's latest forecast is compared with its previous forecast for the same year. A move within 0.5% counts as unchanged. 每家券商的最新预测与其对同一年度的上一次预测比较，变动在 0.5% 以内视为不变。
A surprise needs at least 3 brokers forecasting in the 120 days before the filing. FY2025 had 0 and FY2024 had 1. 惊喜幅度需公告前120天内至少3家券商预测；FY2025仅0家；FY2024仅1家。